Symbiox Investment & Trading Co Ltd (BOM:539278)
India · Delayed Price · Currency is INR 2.700
-0.040 (-1.46%)
At close: Jul 11, 2025
BOM:539278 Revenue
In the fiscal year ending March 31, 2025, Symbiox Investment & Trading Co had annual revenue of 27.64M INR, down -29.12%. Symbiox Investment & Trading Co had revenue of 12.45M in the quarter ending March 31, 2025, with 10.92% growth.
Revenue
27.64M
Revenue Growth
-29.12%
P/S Ratio
3.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27.64M | -11.35M | -29.12% |
| Mar 31, 2024 | 38.99M | -844.95K | -2.12% |
| Mar 31, 2023 | 39.83M | 21.53M | 117.60% |
| Mar 31, 2022 | 18.31M | -12.57M | -40.71% |
| Mar 31, 2021 | 30.88M | 10.90M | 54.60% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |